Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

‘More research’ needed on CBD oil - BVA
BVA said there is a lack of robust evidence to demonstrate the safety and efficacy of CBD in pets.
Small pilot study suggests it can reduce epileptic seizures 

The British Veterinary Association has said more research is needed on the potential benefits and risks of cannabidiol (CBD) before proper regulation is brought in.

This follows a new pilot study by Colorado State University, which found that CBD oil could reduce the frequency of seizures in dogs with epilepsy, when given alongside conventional treatment.

The small study of 16 dogs assessed the short-term effect of CBD on seizure frequency. Nine dogs were treated with CBD for 12 weeks, while seven received a placebo. All dogs continued to receive standard anticonvulsant drugs, including phenobarbital and potassium bromide.

Of the dogs who received CBD, 89 per cent saw a reduction in the number of seizures they experienced. Researchers said there was a significant correlation between the degree of seizure reduction and the amount of CBD concentration in the dog’s blood. The findings have been published in the Journal of the American Veterinary Medical Association.

Responding to the study, BVA said there is a lack of robust evidence to demonstrate the safety and efficacy of CBD in pets.

Junior vice president Daniella Dos Santos said: “The use of cannabidiol (CBD) to treat pets is a live issue in the veterinary profession. While research is ongoing to look into its efficacy and risks, there is currently a lack of sufficient robust evidence to demonstrate health benefits and safety of CBD use in pets.
 
“The veterinary medicines regulator has stated that any products containing CBD must be regulated as a medicine, supported by scientific evidence and rigorously tested. At present no CBD-based products have been granted veterinary marketing authorisation in the UK.”

Pet owners who are concerned about their pet’s health should speak to their local vet for professional advice on safe and effective treatments, she added.

The Colorado team are now working on further research to determine whether a higher dosage could reduce seizures by more than 50 per cent. The study, which launched in January last year, aims to enrol 60 dogs. 

Become a member or log in to add this story to your CPD history

Rabbit Awareness Week set to return this summer

News Story 1
 Rabbit Awareness Week (RAW) is returning this summer, running from 24-28 June 2024. The theme for this year will be 'Healthy Diet, Happy Bunnies'.

The focus on rabbits' diet comes after the most recent PDSA Animal Wellbeing (PAW) Report report revealed that 42 per cent of veterinary professionals identified inappropriate diet as one of the five most important rabbit welfare issues that need to be address.

The campaign will include veterinary blogs, videos, and digital waiting room resources. Practices can sign up to receive updates about RAW. 

Click here for more...
News Shorts
CVS Group hit by cyber attack

CVS Group, which owns more than 450 veterinary practices in the UK, has been hit by a cyber attack.

In a statement, the group said the incident involved unauthorised external access to a limited number of its IT systems. As soon as the attack was discovered, the group took its IT systems temporarily offline, causing 'considerable operational disruption'.

It has warned that the security steps taken and ongoing plans to move its operational systems and IT infrastructure to the Cloud are likely to have an ongoing impact over a number of weeks.

Due to the risk that personal information was accessed, CVS has informed the Information Commissioner's Office. The company is working with third party consultants to investigate the incident.